Creation of hypoestrogenic (GnRH agonists), hyperandrogenic (danazol, gestrinone), or hyperprogestogenic (oral contraceptives, progestins) environments result in the suppression of endometrial and endometriosis cell proliferation. Here, GNRH1 is linked to endometriosis.